Embolic Protection Device Market Size, Share & Analysis | Global | 2024 – 2030 | MedCore | Includes: Carotid Embolic Protection Devices, Renal Embolic Protection Devices, and 1 more

  • Year: 2024
  • Scope: 10 Years
  • Region: Global
  • Type: MedCore

Product Description

Overall, the global embolic protection device market was valued at $110 million in 2023. This is expected to increase over the forecast period at a CAGR of 0.6% to reach $115 million.

The full report suite on the global market for embolic protection devices (EPDs) includes a meticulous examination across seven prominent geographical regions, namely North America, Latin America, Western Europe, Central and Eastern Europe, the Middle East, Asia Pacific and Africa. Within each of these delineated regions, a comprehensive scrutiny will be conducted encompassing various facets, including market valuation, unit analysis and ASP. Moreover, the report will extend its projections up to the year 2030, thereby providing a comprehensive and anticipatory understanding of the market trends and trajectories for the given period.

DATA TYPES INCLUDED

  • Procedure Numbers, Unit SalesAverage Selling PricesMarket Value & Growth Trends
  • Forecasts Until 2030, and Historical Data to 2020
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • COVID19 Impact
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

Global Embolic Protection Device Market Analysis

Global Embolic Protection Device Market

Global Embolic Protection Device Market Share Analysis

Global Embolic Protection Device Market

In 2015, Medtronic entered the U.S. EPD market by acquiring Covidien, gaining the SpiderFX™ device with approvals for carotid, lower limb, and saphenous vein grafting indications. As of 2023, Medtronic’s SpiderFX™ leads the standalone EPD market for lower-limb procedures.

Abbott Vascular, entering the EPD market in 2006, acquired Guidant’s platforms, becoming the first to offer a carotid-approved EPD. Abbott’s enduring market presence is marked by innovations like the sixth-gen Emboshield® NAV6 system in 2009 and the expanded RX Accunet® EPD indication in 2011.

Boston Scientific’s FilterWire EZ™ is designed for carotid and SVG indications, providing embolic protection across vessel sizes. The 2018 acquisition of Claret Medical added the Sentinel™ cerebral protection system, enhancing Boston Scientific’s TAVR product line with improved market synergy.

Market Segmentation Summary

  • Carotid Embolic Protection Device Market
  • Renal Embolic Protection Device Market
  • Lower-Limb Embolic Protection Device Market

Global Research Scope Summary

Report AttributeDetails
RegionsNorth America (Canada, United States)
Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela)
Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.)
Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine)
Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates)
Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam)
Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year2023
Forecast2024-2030
Historical Data2020-2023
Quantitative CoverageMarket Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative CoverageCOVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data SourcesPrimary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

CONTACT US FOR ADDITIONAL INFORMATION

For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.

 

FREE Sample Report

 

embolic protection device Market
14.1 Executive Summary
14.1.1 Global Embolic Protection Device Market Overview
14.1.2 Competitive Analysis
14.1.3 Procedures Included
14.1.4 Markets Included
14.1.5 Regions Included
14.2 Introduction
14.2.1 Protection Mechanism
14.2.1.1 Filter Basket
14.2.1.2 Distal Balloon Occlusion
14.2.1.3 Flow Redirection
14.3 Procedure Numbers
14.4 Market Overview
14.4.1 By Segment
14.4.2 By Region
14.5 Market Analysis and Forecast
14.5.1 Total Embolic Protection Device Market
14.5.2 Carotid EPD Market
14.5.3 Renal EPD Market
14.5.4 Lower-Limb EPD Market
14.6 Drivers and Limiters
14.6.1 Market Drivers
14.6.2 Market Limiters
14.7 Competitive Market Share Analysis
Medtronic
Abbott Vascular
Boston Scientific
Cardinal Health
Others
Chart 14‑1: Embolic Protection Device Market, Global, 2023 & 2030
Chart 14‑2: Embolic Protection Device Procedures, Global, 2023
Chart 14‑3: Embolic Protection Device Procedures by Region, Global, 2020 – 2030
Chart 14‑4: Embolic Protection Device Market by Segment, Global, 2020 – 2030
Chart 14‑5: Embolic Protection Device Market by Region, Global, 2020 – 2030
Chart 14‑6: Leading Competitors, Embolic Protection Device Market, Global, 2023
Figure 14‑1: Embolic Protection Device Procedures Covered
Figure 14‑2: Embolic Protection Device Markets Covered
Figure 14‑3: Embolic Protection Device Regions Covered, Global (1 of 2)
Figure 14‑4: Embolic Protection Device Regions Covered, Global (2 of 2)
Figure 14‑5: Embolic Protection Device Procedures by Region, Global, 2020 – 2030
Figure 14‑6: Embolic Protection Device Procedures by Country, North America, 2020 – 2030
Figure 14‑7: Embolic Protection Device Procedures by Country, Latin America, 2020 – 2030 (1 of 2)
Figure 14‑8: Embolic Protection Device Procedures by Country, Latin America, 2020 – 2030 (2 of 2)
Figure 14‑9: Embolic Protection Device Procedures by Country, Western Europe, 2020 – 2030
Figure 14‑10: Embolic Protection Device Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)
Figure 14‑11: Embolic Protection Device Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)
Figure 14‑12: Embolic Protection Device Procedures by Country, Middle East, 2020 – 2030
Figure 14‑13: Embolic Protection Device Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)
Figure 14‑14: Embolic Protection Device Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)
Figure 14‑15: Embolic Protection Device Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)
Figure 14‑16: Embolic Protection Device Procedures by Country, Africa, 2020 – 2030
Figure 14‑17: Embolic Protection Device Market by Segment, Global, 2020 – 2030 (US$M)
Figure 14‑18: Embolic Protection Device Market by Region, Global, 2020 – 2030 (US$M)
Figure 14‑19: Embolic Protection Device Market, Global, 2020 – 2030
Figure 14‑20: Units Sold by Region, Embolic Protection Device Market, Global, 2020 – 2030
Figure 14‑21: Average Selling Price by Region, Embolic Protection Device Market, Global, 2020 – 2030 (US$)
Figure 14‑22: Market Value by Region, Embolic Protection Device Market, Global, 2020 – 2030 (US$M)
Figure 14‑23: Carotid EPD Market, Global, 2020 – 2030
Figure 14‑24: Units Sold by Region, Carotid EPD Market, Global, 2020 – 2030
Figure 14‑25: Average Selling Price by Region, Carotid EPD Market, Global, 2020 – 2030 (US$)
Figure 14‑26: Market Value by Region, Carotid EPD Market, Global, 2020 – 2030 (US$M)
Figure 14‑27: Renal EPD Market, Global, 2020 – 2030
Figure 14‑28: Units Sold by Region, Renal EPD Market, Global, 2020 – 2030
Figure 14‑29: Average Selling Price by Region, Renal EPD Market, Global, 2020 – 2030 (US$)
Figure 14‑30: Market Value by Region, Renal EPD Market, Global, 2020 – 2030 (US$M)
Figure 14‑31: Lower-Limb EPD Market, Global, 2020 – 2030
Figure 14‑32: Units Sold by Region, Lower-Limb EPD Market, Global, 2020 – 2030
Figure 14‑33: Average Selling Price by Region, Lower-Limb EPD Market, Global, 2020 – 2030 (US$)
Figure 14‑34: Market Value by Region, Lower-Limb EPD Market, Global, 2020 – 2030 (US$M)
Figure 14‑35: Leading Competitors, Embolic Protection Device Market, Global, 2023

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Options

Report Summary

FREE

Select License Type

Overall, the global EPD market was valued at $110 million in 2023. This is expected to increase over the forecast period at a CAGR of 0.6% to reach $115 million.

  • 2024
  • 10 Years
  • Global
  • MedCore
0
    0
    Your Cart
    Your cart is emptyReturn to Report Library